The role of obesity in promoting the LIF/LIFR signaling in triple negative breast cancer

被引：0
|
作者：
Randolph, Lois
Sanchez, Alondra Rodriguez
Blankenship, Logan
Pratap, Uday P.
Yang, Xue
Panneerdoss, Durga Meenakshi
Konda, Swapna
Santhamma, Bindu
Sareddy, Gangadhara R.
Rao, Manjeet K.
Kost, Edward R.
Tekmal, Rajeshwar R.
Nair, Hareesh B.
Vadlamudi, Ratna K.
Viswanadhapalli, Suryavathi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3408
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Examining the role of obesity and leptin signaling in triple negative breast cancer.
    Brock, Courtney
    Wright, Maryl
    Nguyen, Khoa
    Hebert, Katherine
    Alzoubi, Madlin
    Cheng, Thomas
    Collins-Burow, Bridgette
    Burow, Matthew
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [2] Targeting LIF/LIFR signaling in cancer
    Viswanadhapalli, Suryavathi
    Dileep, Kalarickal, V
    Zhang, Kam Y. J.
    Nair, Hareesh B.
    Vadlamudi, Ratna K.
    [J]. GENES & DISEASES, 2022, 9 (04) : 973 - 980
  • [3] The role of adiposity in enhancing LIF/LIFR signaling pathway in endometrial cancer
    Blankenship, Logan
    Viswanadhapalli, Suryavathi
    Altwegg, Kristin
    Tekmal, Rajeshwar Rao
    Valente, Philip
    Kost, Edward
    Vadlamudi, Ratna
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S303 - S303
  • [4] Therapeutic utility of EC359 for targeting oncogenic LIFR signaling in triple negative breast cancer
    Viswanadhapalli, Suryavathi
    Li, Mengxing
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Santhamma, Bindu
    Zhou, Mei
    Ma, Shihong
    Sonavane, Rajni
    Pratap, Uday P.
    Altwegg, Kristin A.
    Chang, Annabel
    Chavez-Riveros, Alejandra
    Dileep, Kalarickal V.
    Zhang, Kam Y.
    Bajda, Marek
    Raj, Ganesh V.
    Brenner, Andrew
    Manthati, Vijaya
    Rao, Manjeet
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] Role of adipocytokines in obesity associated Triple Negative Breast Cancer
    Sultana, Rizwana
    Kataki, Amal Ch
    Barthakur, Bibhuti Bhusan
    Bose, Sujoy
    [J]. CANCER RESEARCH, 2017, 77 (22)
  • [6] Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer
    Viswanadhapalli, S.
    Luo, Y.
    Sareddy, G. R.
    Santhamma, B.
    Zhou, M.
    Li, M.
    Pratap, U. P.
    Altwegg, K. A.
    Li, X.
    Srinivasan, U.
    Ma, S.
    Chang, A.
    Riveros, A. C.
    Zhang, K. Y.
    Dileep, K. V.
    Pan, X.
    Murali, R.
    Bajda, M.
    Raj, G.
    Brenner, A.
    Manthati, V.
    Rao, M.
    Tekmal, R. R.
    Nair, H. B.
    Nickisch, K. J.
    Vadlamudi, R. K.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [7] The Functional Role of Notch Signaling in Triple-Negative Breast Cancer
    Speiser, Jodi J.
    Ersahin, Cagatay
    Osipo, Clodia
    [J]. HORMONES AND BREAST CANCER, 2013, 93 : 277 - 306
  • [8] The role of purinergic signaling in the chemotherapy response of triple negative breast cancer
    Manouchehri, Jasmine
    Datta, Jharna
    Cherian, Mathew
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [9] Obesity and Prognosis in Triple Negative Breast Cancer
    Burkbauer, Laura
    Goldbach, Macy
    Allison, Kelly C.
    Tchou, Julia C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S38 - S39
  • [10] Physical activity and breast cancer: Role of inhibition of Wnt signaling in triple negative breast cancer
    Altundag, Kadri
    [J]. JOURNAL OF BUON, 2020, 25 (01): : 582 - 582
12345